Jermyn Street Associates

Jermyn Street Associates is a private U.S. limited liability company that appears to function as an investment vehicle rather than an operating life sciences, biotech, pharma, or healthcare company. Publicly available information primarily links it to SEC beneficial ownership filings, including Schedule 13D disclosures related to holdings in Inotiv. There is no evidence that Jermyn Street Associates develops therapeutics, operates a clinical pipeline, manufactures healthcare products, or provides CRO/CDMO services. Based on the available record, it should be classified as a non-operating investment/holding entity with some exposure to healthcare-related public equities rather than a healthcare company itself.